← FDA Drug Approvals (Drugs@FDA)

MEDROXYPROGESTERONE ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMPHASTAR PHARMS INC · Approved 2017-11-28

Drug application

FDA Application #
ANDA077334
Application type
Abbreviated New Drug Application (Generic)
Brand name
MEDROXYPROGESTERONE ACETATE
Generic name
MEDROXYPROGESTERONE ACETATE
Active ingredients
MEDROXYPROGESTERONE ACETATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
AMPHASTAR PHARMS INC
Manufacturer
Amphastar Pharmaceuticals, Inc.
First approval
2017-11-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown